Richard A. Waldron

Insider Reports History

Reporting-owner location: San Mateo, CA
Latest reporting-owner signature: Christian Vasquez, as Attorney-in-Fact for Richard A. Waldron
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Richard A. Waldron

Form 4 holding Former Chief Financial Officer

BioAtla, Inc.

Security class: Common Stock
Shares / value: 343,421
Estimated value: $84,824
Report date: 28 Feb 2026
Price: $0.2470
Ownership: Direct

Insider Reports Filed by Richard A. Waldron

4 BCAB

BioAtla, Inc.

Report period: 28 Feb 2026
Transactions: 1
Transaction value: -$674
Accepted by SEC: 02 Mar 2026, 18:14
Role: Former Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 30 Nov 2025
Transactions: 1
Transaction value: -$2,143
Accepted by SEC: 01 Dec 2025, 18:37
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 Aug 2025
Transactions: 1
Transaction value: -$1,080
Accepted by SEC: 02 Sep 2025, 19:07
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 May 2025
Transactions: 1
Transaction value: -$970
Accepted by SEC: 03 Jun 2025, 16:30
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 11 Mar 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 13 Mar 2025, 16:12
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 15 Feb 2025
Transactions: 1
Transaction value: -$5,008
Accepted by SEC: 24 Feb 2025, 20:30
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 15 Feb 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 20 Feb 2024, 16:22
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 Oct 2023
Transactions: 1
Transaction value: -$1,426
Accepted by SEC: 02 Nov 2023, 12:26
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 30 Sep 2023
Transactions: 1
Transaction value: -$1,649
Accepted by SEC: 02 Oct 2023, 18:06
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 Aug 2023
Transactions: 1
Transaction value: -$2,435
Accepted by SEC: 01 Sep 2023, 20:06
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 Jul 2023
Transactions: 1
Transaction value: -$2,900
Accepted by SEC: 01 Aug 2023, 17:44
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 30 Jun 2023
Transactions: 1
Transaction value: -$2,910
Accepted by SEC: 03 Jul 2023, 17:42
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 May 2023
Transactions: 1
Transaction value: -$3,056
Accepted by SEC: 01 Jun 2023, 20:25
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 30 Apr 2023
Transactions: 1
Transaction value: -$3,269
Accepted by SEC: 02 May 2023, 18:03
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 Mar 2023
Transactions: 1
Transaction value: -$2,600
Accepted by SEC: 03 Apr 2023, 20:03
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 09 Feb 2023
Transactions: 2
Transaction value: -$2,891
Accepted by SEC: 01 Mar 2023, 17:32
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 Jan 2023
Transactions: 1
Transaction value: -$4,336
Accepted by SEC: 02 Feb 2023, 18:10
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 Dec 2022
Transactions: 1
Transaction value: -$8,002
Accepted by SEC: 03 Jan 2023, 16:06
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 30 Nov 2022
Transactions: 1
Transaction value: -$10,680
Accepted by SEC: 01 Dec 2022, 20:06
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 Oct 2022
Transactions: 1
Transaction value: -$6,683
Accepted by SEC: 01 Nov 2022, 19:57
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 30 Sep 2022
Transactions: 1
Transaction value: -$7,469
Accepted by SEC: 04 Oct 2022, 19:47
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 Aug 2022
Transactions: 1
Transaction value: -$8,449
Accepted by SEC: 01 Sep 2022, 18:49
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 Jul 2022
Transactions: 1
Transaction value: -$3,298
Accepted by SEC: 01 Aug 2022, 18:28
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 30 Jun 2022
Transactions: 1
Transaction value: -$2,764
Accepted by SEC: 01 Jul 2022, 17:25
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 May 2022
Transactions: 1
Transaction value: -$2,338
Accepted by SEC: 03 Jun 2022, 18:05
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 30 Apr 2022
Transactions: 1
Transaction value: -$3,376
Accepted by SEC: 06 May 2022, 17:01
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 Mar 2022
Transactions: 1
Transaction value: -$4,850
Accepted by SEC: 04 Apr 2022, 21:15
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 28 Feb 2022
Transactions: 1
Transaction value: -$6,286
Accepted by SEC: 04 Mar 2022, 16:07
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 21 Feb 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 24 Feb 2022, 20:18
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 Jan 2022
Transactions: 1
Transaction value: -$10,994
Accepted by SEC: 02 Feb 2022, 16:46
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 31 Dec 2021
Transactions: 1
Transaction value: -$27,305
Accepted by SEC: 05 Jan 2022, 19:35
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 30 Nov 2021
Transactions: 8
Transaction value: -$333,148
Accepted by SEC: 07 Dec 2021, 16:44
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 29 Nov 2021
Transactions: 1
Transaction value: -$109,870
Accepted by SEC: 06 Dec 2021, 19:44
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 22 Nov 2021
Transactions: 6
Transaction value: -$336,838
Accepted by SEC: 30 Nov 2021, 19:07
Role: Chief Financial Officer
Next action: Open filing details

4 BCAB

BioAtla, Inc.

Report period: 14 Jun 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 16 Jun 2021, 21:29
Role: Chief Financial Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .